Figure 1: Lung biopsy and genetic testing occurrences by primary disease category.
A. Data is based on the 110 unique patients, 35.9% of the overall cohort, who underwent lung biopsy. B. Data is based on the 149 unique patients, 48.7% of the overall cohort, who underwent genetic testing. NEHI: Neuroendocrine cell Hyperplasia of Infancy; ILD NOS: interstitial lung disease not otherwise specified